Product Description
Daniel H. Present, MD, Clinical Professor of Medicine at the Mount Sinai School of Medicine, discusses the latest thinking regarding the diagnosis and management of inflammatory bowel disease (Crohn’s disease and ulcerative colitis). Within the context of hypothetical patient cases, Dr. Present discusses the differential diagnosis of inflammatory bowel disease and the various treatment options for mild-to-moderate and moderate-to-severe disease, including the therapeutic role of 5-ASA drugs, immune modifiers, and other agents. The investigational use of antibody to tumor necrosis factor [alpha] [alpha] in treatment-resistant Crohn’s disease is also addressed.
Inflammatory Bowel Disease: Diagnosis and Management of Crohn’s Disease and Ulcerative Colitis
| 
| 
| 
| 
| 
| 